Medical Journals

Prolyl-isomerase Pin1 Accumulates in Lewy Bodies of Parkinson Disease and Facilitates Formation of Alpha-synuclein Inclusions.

Authors:
  • Ryo Akihide
  • Togo Takashi
  • Nakai Toshiki
  • Hirai Akiko
  • Nishi Mayuko
  • Yamaguchi Akira
  • Suzuki Kyoko
  • Hirayasu Yoshio
  • Kobayashi Hideki
  • Perrem Kilian
  • Liou Yih-Cherng
  • Aoki Ichiro

From: Department of Pathology, Yokohama City University School of Medicine, Japan.

The Journal of biological chemistry

  • Publish Date: Feb 2006
  • ISSN: 0021-9258
  • Volume: 281
  • Issue: 7
  • Pages: 4117-25
  • Medium: Print
  • Language: English
  • Citation (JAMA): Ryo Akihide, Togo Takashi, Nakai Toshiki, et al. Prolyl-isomerase Pin1 Accumulates in Lewy Bodies of Parkinson Disease and Facilitates Formation of Alpha-synuclein Inclusions.. J. Biol. Chem. Feb 2006;281:4117-25

Abstract

Parkinson disease (PD) is a relatively common neurodegenerative disorder that is characterized by the loss of dopaminergic neurons and by the formation of Lewy bodies (LBs), which are cytoplasmic inclusions containing aggregates of alpha-synuclein. Although certain post-translational modifications of alpha-synuclein and its related proteins are implicated in the genesis of LBs, the specific molecular mechanisms that both regulate these processes and initiate subsequent inclusion body formation are not yet well understood. We demonstrate in our current study, however, that the prolyl-isomerase Pin1 localizes to the LBs in PD brain tissue and thereby enhances the formation of alpha-synuclein immunoreactive inclusions. Immunohistochemical analysis of brain tissue from PD patients revealed that Pin1 localizes to 50-60% of the LBs that show an intense halo pattern resembling that of alpha-synuclein. By utilizing a cellular model of alpha-synuclein aggregation, we also demonstrate that, whereas Pin1 overexpression facilitates the formation of alpha-synuclein inclusions, dominant-negative Pin1 expression significantly suppresses this process. Consistent with these observations, Pin1 overexpression enhances the protein half-life and insolubility of alpha-synuclein. Finally, we show that Pin1 binds synphilin-1, an alpha-synuclein partner, via its Ser-211-Pro and Ser-215-Pro motifs, and enhances its interaction with alpha-synuclein, thus likely facilitating the formation of alpha-synuclein inclusions. These results indicate that Pin1-mediated prolyl-isomerization plays a pivotal role in a post-translational modification pathway for alpha-synuclein aggregation and in the resultant Lewy body formations in PD.

Mesh Headings (Keywords): Amino Acid Sequence, Animals, Binding Sites, COS Cells, Carrier Proteins, Casein Kinase II, Cercopithecus aethiops, Half-Life, Humans, Lewy Bodies, Molecular Sequence Data, Nerve Tissue Proteins, Parkinson Disease, Peptidylprolyl Isomerase, Phosphorylation, Protein Processing, Post-Translational, Solubility, alpha-Synuclein


Check for Full Text / PubMed Unique Identifier (PMID): 16365047


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.